Le Lézard
Classified in: Health
Subject: SVY

6th Perinatal Stem Cell Society Congress | Salt Lake City, United States - March 4th-6th, 2020


DUBLIN, Jan. 17, 2020 /PRNewswire/ -- The "6th Perinatal Stem Cell Society Congress" conference has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The International Perinatal Stem Cell Society, Inc. is a non-profit organization founded on the basic principle that stem cells from perinatal tissues contain enormous, untapped life potential to treat many diseases and disorders.

Benefits of Registration

Agenda

Thursday, March 5, 2020

7:00 - 8:25 Breakfast in Exhibit Hall

8:25 - 8:30
Kyle Cetrulo
Welcome

8:30 - 9:00
Renee Nordland
How Cord Tissue Change My Son's Life

9:00 - 9:30
Frances Verter, PhD
Clinical Trials with Perinatal Tissues and Cells

9:30 - 10:00
Tomasz Baran MD, MBA
FamiCord's Clinical Experience with WJ Derived Products in Multiple Clinical Applications

10:00 - 10:30 Exhibit Hall Break

10:30 - 11:00
Neil Riordan, PA, PhD
Results From Panama Clinical Trials Using Umbilical Cord MSCs: MultioleSclerosis and Autism

11:00 - 12:00
Joanne Kurtzberg, MD
Extending Perinatal Therapies for the Brain

12:00 - 1:00 Lunch

1:00 - 1:30
Rouzbeh R. Taghizadeh, PhD
Umbilical Cord Tissue Processing Technologies for Perinatal MSC Banking

1:30 - 2:00
Serhiy Forostyak, MD
Perinatal Tissue Derivatives in Tissue Regeneration: From Research to Clinical Applications

2:00 - 2:30
Joshua Hare, MD
Comparison of Umbilical Cord Tissue MSCs and Bone Marrow MSCs

2:30 - 3:00
Rebeca Lim, PhD
Exosome Therapy for Bronchopulmonary Dysplasia - Are We Ready for Cell-free Regenerative Medicine?

3:00 - 3:30 Exhibit Hall Break

3:30 - 4:00
Timothy Ganey, PhD
Quantification of Exosome Product

4:00 - 4:30
Ben Noren
Cell Microencapsulation for Enhanced Regeneration of Tissues

4:30 - 5:00
John Wetherell, PhD
Understand How IP Drives Your Company Decision Making Process

Networking Cocktail Reception & Dinner

Friday, March 6, 2020

7:00 - 8:30 Breakfast in Exhibit Hall

8:30 - 9:00
Dennis Lox, MD
Why A Successful Sports & Regenerative Medicine Specialist Doesn't Use Perinatal Products

9:00 - 9:30
Duncan Ross, PhD
Exosome Characterization and Visualization

9:30 - 10:00
Saadiq F. El-Amin III, MD, PhD
Regenerative Medicine in Elite and Professional Athletes

10:00 - 10:30 Exhibit Hall Break

10:30 - 11:00
Regan Archibald, LAc, FMP, CSSAc
Ending the Pain Crisis with TCM, Peptides and Perinatal Allographs

11:00 - 11:30
Ian White, PhD
Regeneration 101: Amniosomes in Regenerative Medicine

11:30 - 1:00 Lunch

1:00 - 1:30
FDA Representative
An Update on the FDA's Stance on Perinatal Products and the 361 Industry

1:30 - 2:00
Mike Druckman
Regulatory Questions All 361 Companies Should Understand

2:00 - 2:30
Barbara Krutchkoff, PhD FAARM
A Road Map to Compliance

2:30 - 3:00 Panel
FDA Representative
Mike Druckman
Barbara Krutchkoff, PhD
Timothy Ganey, PhD

3:00 - 3:30 Exhibit Hall Break

3:30 - 4:00
Jeremy J. Lim, PhD
Biological Properties of Dehydrated Human Amnion/Chorion Membrane and Umbilical Cord Allografts for Soft Tissue Healing

4:00 - 4:30
Sean Murphy, PhD
Amnion Membrane-Derived Cells and Materials for Skin Wound Treatment

4:30 - 5:00
Ramon Coronado, MSc, PhD
Exosomes to Treat Cancer

For more information about this conference visit https://www.researchandmarkets.com/r/e41eo0

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 03:52
The progressive decrease in hearing in elderly people can represent a major problem for their quality of life: it has in fact been demonstrated that critical issues such as these, in addition to being a problem as such, can...

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...



News published on and distributed by: